Skip to main content
NCD 190.25 · version 1 · Laboratory NCD

NCD 190.25: Alpha-fetoprotein

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026); Lab NCD code lists: October 2026 (effective October 1, 2026). Next CMS release: weekly, every Thursday for the Medicare Coverage Database NCDs; January 1, 2027 (quarterly update) for the Lab NCD code lists.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 190.25

Benefit category
Diagnostic Laboratory Tests
Effective date
11/25/2002
Implemented 01/01/2003
Transmittal
Transmittal 17
Versions published
1
Manual section
190
Pathology and Laboratory, NCD Manual (Pub. 100-03) chapter 1 part 3
Lab edit list
155 covered ICD-10
233 non-covered

TL;DR

NCD 190.25 sets Medicare's national policy for alpha-fetoprotein under the benefit category "Diagnostic Laboratory Tests", effective 11/25/2002 and implemented 01/01/2003. AFP is useful for the diagnosis of hepatocellular carcinoma in high-risk patients (such as alcoholic cirrhosis, cirrhosis of viral etiology, hemochromatosis, and alpha 1-antitrypsin deficiency) and in separating patients with benign hepatocellular neoplasms… As a laboratory NCD it carries a national ICD-10 edit list: 155 diagnosis codes support medical necessity and 233 are denied, applied automatically by every Medicare contractor to 1 procedure code.

Item or service described

AFP is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain malignancies to therapy.

Indications and limitations of coverage

Indications

AFP is useful for the diagnosis of hepatocellular carcinoma in high-risk patients (such as alcoholic cirrhosis, cirrhosis of viral etiology, hemochromatosis, and alpha 1-antitrypsin deficiency) and in separating patients with benign hepatocellular neoplasms or metastases from those with hepatocellular carcinoma and, as a non-specific tumor associated antigen, serves in marking germ cell neoplasms of the testis, ovary, retroperitoneum, and mediastinum.

Note: Scroll down for links to the quarterly Covered Code Lists (including narrative).

Text reproduced from the CMS Medicare Coverage Database record for NCD 190.25 version 1. View the original on cms.gov.

Laboratory NCD code lists (October 2026)

Medicare contractors apply this NCD through a national edit: the procedure codes below are paid only when the claim carries a covered diagnosis. The October 2026 list holds 155 covered and 233 non-covered ICD-10-CM codes; any code not on the list does not support medical necessity.

1 procedure code are edited against this NCD's diagnosis list. CPT codes are shown as numbers only; descriptors are licensed by the AMA.

Procedure codes subject to NCD 190.25
CodeCode set
82105CPT (descriptor licensed by AMA)

What Medicare pays for these tests: 1 of the 1 codes carry a national payment amount on the October 2026 Clinical Laboratory Fee Schedule, from $16.77, with no deductible or coinsurance. QW marks the CLIA-waived variant of a test.

Clinical Laboratory Fee Schedule amounts for the codes NCD 190.25 edits, October 2026
CodeCLFS amountWith QWPricing
82105$16.77—national payment amount
Source: CMS Clinical Laboratory Fee Schedule 26CLABQ4. Every code range and the October changes are on the Clinical Laboratory Fee Schedule page.

The first 40 of 155 covered diagnosis codes, with FY2027 ICD-10-CM descriptions. A claim with any covered code on the line supports medical necessity under the national edit.

Covered ICD-10-CM codes for NCD 190.25 (sample)
ICD-10-CMDescriptionEffective
A52.74Syphilis of liver and other viscera2015-10-01
B18.0Chronic viral hepatitis B with delta-agent2015-10-01
B18.1Chronic viral hepatitis B without delta-agent2015-10-01
B18.2Chronic viral hepatitis C2015-10-01
B66.1Clonorchiasis2015-10-01
B66.3Fascioliasis2015-10-01
C22.0Liver cell carcinoma2015-10-01
C22.1Intrahepatic bile duct carcinoma2015-10-01
C22.2Hepatoblastoma2015-10-01
C22.3Angiosarcoma of liver2015-10-01
C22.4Other sarcomas of liver2015-10-01
C22.7Other specified carcinomas of liver2015-10-01
C22.8Malignant neoplasm of liver, primary, unspecified as to type2015-10-01
C22.9Malignant neoplasm of liver, not specified as primary or secondary2015-10-01
C38.1Malignant neoplasm of anterior mediastinum2015-10-01
C38.2Malignant neoplasm of posterior mediastinum2015-10-01
C38.3Malignant neoplasm of mediastinum, part unspecified2015-10-01
C38.8Malignant neoplasm of overlapping sites of heart, mediastinum and pleura2015-10-01
C44.1321Sebaceous cell carcinoma of skin of right upper eyelid, including canthus2018-10-01
C44.1322Sebaceous cell carcinoma of skin of right lower eyelid, including canthus2018-10-01
C44.1391Sebaceous cell carcinoma of skin of left upper eyelid, including canthus2018-10-01
C44.1392Sebaceous cell carcinoma of skin of left lower eyelid, including canthus2018-10-01
C56.1Malignant neoplasm of right ovary2015-10-01
C56.2Malignant neoplasm of left ovary2015-10-01
C56.3Malignant neoplasm of bilateral ovaries2021-10-01
C56.9Malignant neoplasm of unspecified ovary2015-10-01
C62.00Malignant neoplasm of unspecified undescended testis2015-10-01
C62.01Malignant neoplasm of undescended right testis2015-10-01
C62.02Malignant neoplasm of undescended left testis2015-10-01
C62.10Malignant neoplasm of unspecified descended testis2015-10-01
C62.11Malignant neoplasm of descended right testis2015-10-01
C62.12Malignant neoplasm of descended left testis2015-10-01
C62.90Malignant neoplasm of unspecified testis, unspecified whether descended or undescended2015-10-01
C62.91Malignant neoplasm of right testis, unspecified whether descended or undescended2015-10-01
C62.92Malignant neoplasm of left testis, unspecified whether descended or undescended2015-10-01
C78.1Secondary malignant neoplasm of mediastinum2015-10-01
C78.7Secondary malignant neoplasm of liver and intrahepatic bile duct2015-10-01
C79.60Secondary malignant neoplasm of unspecified ovary2015-10-01
C79.61Secondary malignant neoplasm of right ovary2015-10-01
C79.62Secondary malignant neoplasm of left ovary2015-10-01

233 diagnosis codes deny automatically under this NCD; the first 20 are shown.

Non-covered ICD-10-CM codes for NCD 190.25 (sample)
ICD-10-CMDescription
R99Ill-defined and unknown cause of mortality
Z00.00Encounter for general adult medical examination without abnormal findings
Z00.01Encounter for general adult medical examination with abnormal findings
Z00.110Health examination for newborn under 8 days old
Z00.111Health examination for newborn 8 to 28 days old
Z00.121Encounter for routine child health examination with abnormal findings
Z00.129Encounter for routine child health examination without abnormal findings
Z00.5Encounter for examination of potential donor of organ and tissue
Z00.6Encounter for examination for normal comparison and control in clinical research program
Z00.70Encounter for examination for period of delayed growth in childhood without abnormal findings
Z00.71Encounter for examination for period of delayed growth in childhood with abnormal findings
Z00.8Encounter for other general examination
Z02.0Encounter for examination for admission to educational institution
Z02.1Encounter for pre-employment examination
Z02.2Encounter for examination for admission to residential institution
Z02.3Encounter for examination for recruitment to armed forces
Z02.4Encounter for examination for driving license
Z02.5Encounter for examination for participation in sport
Z02.6Encounter for examination for insurance purposes
Z02.71Encounter for disability determination

Changed in October 2026

The October 2026 lab NCD release made no change to this NCD's ICD-10-CM list: no code was added, removed or given a new result against January 2026. The last change was in January 2026, when CMS added 2 codes.

Codes on this NCD's list by release: October 2025: 386 · January 2026: 388 · October 2026: 388. Every change across the 23 laboratory NCDs is in the lab NCD code-list change report.

Revision history

07/2004 - Published NCD in the NCD Manual without change to narrative contained in PM AB-02-110. Coding guidance now published in Medicare Lab NCD Manual. Effective and Implementation dates NA. ( TN 17 ) (CR 2130)

07/2002 - Implemented NCD. Effective date 11/25/02. Implementation date 1/01/03. ( TN AB-02-110 ) (CR 2130)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 190.25

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 190.25

What does NCD 190.25 cover?

AFP is useful for the diagnosis of hepatocellular carcinoma in high-risk patients (such as alcoholic cirrhosis, cirrhosis of viral etiology, hemochromatosis, and alpha 1-antitrypsin deficiency) and in separating patients with benign hepatocellular neoplasms or metastases from those with hepatocellular carcinoma and, as a non-specific tumor associated antigen, serves in marking germ cell neoplasms of the testis… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 190.25 take effect?

The current version (1) is effective 11/25/2002, implemented 01/01/2003, published in transmittal 17. This is the only published version.

Does a Local Coverage Determination override NCD 190.25?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Which diagnosis codes are covered under NCD 190.25?

The October 2026 laboratory NCD edit list contains 155 ICD-10-CM codes that support alpha-fetoprotein (for example A52.74 Syphilis of liver and other viscera; B18.0 Chronic viral hepatitis B with delta-agent; B18.1 Chronic viral hepatitis B without delta-agent) and 233 codes that deny. The list applies to 82105.

How often does the lab NCD code list for 190.25 change?

CMS updates the laboratory NCD edit module quarterly, with the October release carrying the annual ICD-10-CM code changes. Codes added or deleted mid-year appear in the quarterly change spreadsheets on the Lab NCDs page.

CMS guidance

Medicare Learning Network publications that CMS issues on this topic, cited by ICN and publication date:

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.